After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…
Many founders assume growth slows because of product or market issues. In reality, unclear and undisciplined communication often becomes the hidden bottleneck.
Most traders lose money — not because they lack skill, but because the human brain is poorly designed for probabilistic decision-making. AI is beginning to shift that statistic.
Founders can create frameworks for working through conflict and change when the team is just two or three people, and if done correctly, it can scale with the company.